These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 37093910)
21. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
22. Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis. Kamal SM; Ahmed A; Mahmoud S; Nabegh L; El Gohary I; Obadan I; Hafez T; Ghoraba D; Aziz AA; Metaoei M Liver Int; 2011 Mar; 31(3):401-11. PubMed ID: 21281434 [TBL] [Abstract][Full Text] [Related]
23. A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema. Soheilian M; Eskandari A; Ramezani A; Rabbanikhah Z; Soheilian R Ocul Immunol Inflamm; 2013 Apr; 21(2):124-9. PubMed ID: 23697857 [TBL] [Abstract][Full Text] [Related]
24. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. Shepherd J; Jones J; Takeda A; Davidson P; Price A Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047 [TBL] [Abstract][Full Text] [Related]
25. Functional and anatomic results of up to 24 months aflibercept treatment for diabetic macular edema in real-life setting. Tsapardoni FN; Makri OE; Lagogiannis AP; Tsekouras IK; Chairas N; Pallikari A; Pagoulatos DD; Georgakopoulos CD Hell J Nucl Med; 2019; 22 Suppl 2():47-54. PubMed ID: 31802045 [TBL] [Abstract][Full Text] [Related]
26. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema. Solaiman KA; Diab MM; Abo-Elenin M Retina; 2010; 30(10):1638-45. PubMed ID: 20838357 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of Dexamethasone Implants in Uveitic Macular Edema in Cases with Behçet Disease. Yalcinbayir O; Caliskan E; Ucan Gunduz G; Gelisken O; Kaderli B; Yucel AA Ophthalmologica; 2019; 241(4):190-194. PubMed ID: 30244248 [TBL] [Abstract][Full Text] [Related]
28. Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b. Scotto G; Fazio V; Fornabaio C; Tartaglia A; Di Tullio R; Saracino A; Angarano G Drugs; 2008; 68(6):791-801. PubMed ID: 18416586 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity. Kim M; Jeong S; Sagong M Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671 [TBL] [Abstract][Full Text] [Related]
30. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment. Deuter CME; Zierhut M; Igney-Oertel A; Xenitidis T; Feidt A; Sobolewska B; Stuebiger N; Doycheva D Ocul Immunol Inflamm; 2017 Apr; 25(2):215-220. PubMed ID: 26731514 [TBL] [Abstract][Full Text] [Related]
31. Randomized, double-blind, placebo-controlled clinical trial on the efficacy of 0.5% indomethacin eye drops in uveitic macular edema. Allegri P; Murialdo U; Peri S; Carniglia R; Crivelli MG; Compiano S; Autuori S; Mastromarino A; Zurria M; Marrazzo G Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1463-70. PubMed ID: 24519421 [TBL] [Abstract][Full Text] [Related]
32. Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema. Lasave AF; Schlaen A; Zeballos DG; Díaz-Llopis M; Couto C; El-Haig WM; Arevalo JF Ocul Immunol Inflamm; 2019; 27(2):294-302. PubMed ID: 29157128 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Deuter CM; Kötter I; Günaydin I; Stübiger N; Doycheva DG; Zierhut M Br J Ophthalmol; 2009 Jul; 93(7):906-13. PubMed ID: 19321469 [TBL] [Abstract][Full Text] [Related]
34. Subretinal fluid in uveitic macular edema: effect on vision and response to therapy. Lehpamer B; Moshier E; Goldberg N; Ackert J; Godbold J; Jabs DA Am J Ophthalmol; 2013 Jan; 155(1):143-9. PubMed ID: 23022159 [TBL] [Abstract][Full Text] [Related]
35. Interferon alpha 2b in the treatment of uveitic cystoid macular edema. Butler NJ; Suhler EB; Rosenbaum JT Ocul Immunol Inflamm; 2012 Apr; 20(2):86-90. PubMed ID: 22409560 [TBL] [Abstract][Full Text] [Related]
36. TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA. Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Sainz de la Maza M; Adán A Retina; 2018 Jul; 38(7):1361-1370. PubMed ID: 28520640 [TBL] [Abstract][Full Text] [Related]
37. Interferon-alpha2a and Systemic Corticosteroid in Monotherapy in Chronic Uveitis: Results of the Randomized Controlled BIRDFERON Study. Fardeau C; Simon A; Rodde B; Viscogliosi F; Labalette P; Looten V; Tézenas du Montcel S; LeHoang P Am J Ophthalmol; 2017 May; 177():182-194. PubMed ID: 28315319 [TBL] [Abstract][Full Text] [Related]
39. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT. Tang F; Qin X; Lu J; Song P; Li M; Ma X Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282 [TBL] [Abstract][Full Text] [Related]
40. Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis. Invernizzi A; Iannaccone F; Marchi S; Mastrofilippo V; Coassin M; Fontana L; Salvarani C; McCluskey P; Cimino L Ocul Immunol Inflamm; 2019; 27(4):643-650. PubMed ID: 29470929 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]